Mark Stejbach Insider Trading $TNGN TENGION INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark Stejbach.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark Stejbach. Mark Stejbach is VP & Chief Commercial Officer in TENGION INC ($TNGN) and VP and Chief Commercial Offcr in TENGION INC ($TNGN) and Director in Flexion Therapeutics Inc ($FLXN) and Chief Commercial Officer in Alkermes plc. ($ALKS) and SVP/Chief Comm Off, Alks Inc in Alkermes plc. ($ALKS).

Mark Stejbach in TENGION INC

Trading Symbol: TNGN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Stejbach: VP and Chief Commercial Offcr, VP & Chief Commercial Officer
Holdings: 28,663 shares
Latest Transaction: May 13 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark Stejbach in TENGION INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALKS, FLXN, TNGN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 13 2011TNGNTENGION INCStejbach MarkVP and Chief Commer ...Option ExerciseA2.4240,00096,80040,000
May 13 2011TNGNTENGION INCStejbach MarkVP and Chief Commer ...GrantA0.0026,667028,6632 K to 28.7 K (+1,336.02 %)
Oct 18 2010TNGNTENGION INCStejbach MarkVP and Chief Commer ...Option ExerciseA2.9425,00073,50025,000
Apr 15 2010TNGNTENGION INCStejbach MarkVP & Chief Commerci ...Option ExerciseC0.0027,50000
Apr 15 2010TNGNTENGION INCStejbach MarkVP & Chief Commerci ...BuyC0.001,89601,996100 to 2 K (+1,896.00 %)
Apr 13 2010TNGNTENGION INCStejbach MarkVP & Chief Commerci ...BuyP5.001005001000 to 100

Page:   1